YY1 and neoplasm: In the current study, we used a large (n = 1,176) and well characterised series of patients with early stage invasive breast cancer to investigate the frequency of discordant HER2 gene and protein levels and to evaluate the role of AP-2α/β, AP-2α and YY1 in these tumours.